Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07560813
Recruiting
NOURISH - A Healthcare-community Partnership to Improve Nutrition for Optimal Glycemic Control and Pregnancy Outcomes With Pregestational Diabetes
Not applicable · United States · 1 site
Registry update: 14 Aug 2026
NCT07710495
Recruiting
Exercise to Improve Outcomes in Pancreatic Cancer
Not applicable · United Kingdom · 1 site
Registry update: 17 Jul 2026
NCT07693868
Recruiting
A Study to See How Safe a New Medicine (NNC6022-0004) is in Healthy People and People Living With Obesity
Phase 1 · Netherlands · 1 site
Registry update: 1 Sept 2026
NCT07631637
Recruiting
Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Phase 2 · Spain, Italy, Puerto Rico, United States · 33 sites
Registry update: 26 Oct 2026
NCT07600164
Recruiting
Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer
Phase 4 · China · 1 site
Registry update: 13 Jul 2026
NCT07582133
Recruiting
A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Primary IgA Nephropathy
Phase 2 · China · 1 site
Registry update: 22 Jul 2026
NCT07577336
Recruiting
Portable MRI for Pediatric Hypoxic Ischemic Brain Injury
Not applicable · United States · 1 site
Registry update: 24 Sept 2026
NCT07409831
Recruiting
Incretin-based Therapies, Nutrition, and Physical Activity
Not applicable · Canada · 1 site
Registry update: 16 Jul 2026
NCT07835035
Recruiting
Rimegepant Plus Toripalimab in Advanced Urothelial Carcinoma After Failure of Standard Therapy
Phase 1 · China · 2 sites
Registry update: 22 Sept 2026
NCT07586124
Recruiting
Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma
Phase 2 · China · 15 sites
Registry update: 9 Jul 2026
NCT07725471
Recruiting
COMPARISON OF BREATHING AND SUBOCCIPITAL RELEASE IN STROKE
Not applicable · 1 site
Registry update: 24 Jul 2026
NCT07680803
Recruiting
Gene-Modified Stem Cell Therapy for Subjects With Transfusion-dependent Beta-thalassemia
Phase 2 · Italy · 2 sites
Registry update: 27 Jul 2026
NCT07733024
Recruiting
Comparing DLL3 PET/CT to Standard Scans in Neuroendocrine Cancer
Phase 2 · China · 2 sites
Registry update: 28 Sept 2026
2025-522349-23-00
Recruiting
Post-INFECT: Investigating Neuroinflammation and its effects in post-COVID syndrome
Phase 3 · Netherlands · 1 site
Registry update: 1 Jun 2026
2025-522348-42-00
Recruiting
Locating microclots with PET in post-COVID syndrome
Phase 1/2 · Netherlands · 1 site
Registry update: 7 May 2026
NCT07387926
Recruiting
Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
Phase 1/2 · Australia, Israel, South Korea, Taiwan · 4 sites
Registry update: 15 Oct 2026
NCT07681245
Recruiting
Label-free Femtosecond Laser Imaging Combined With the Fast Lung Artificial Intelligence Model for Rapid Intraoperative Diagnosis of Lung Surgical Specimens: A Multicentre, Prospective, Parallel-workflow, Non-inferiority Study.
Not applicable · China · 5 sites
Registry update: 26 Oct 2026
NCT07460765
Recruiting
Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 1 · United States · 1 site
Registry update: 16 Oct 2026
2024-518437-28-00
Recruiting
Lidocaine for opioid sparing in vaso-occlusive crisis of Sickle Cell Disease
Phase 3 · France · 12 sites
Registry update: 3 Sept 2026
NCT07670416
Recruiting
A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes
Phase 3 · China · 21 sites
Registry update: 5 Nov 2026

Ordered by registry start date. Freshness and sponsorship never change the order.